Market Resilience: Silence Therapeutics Plc ADR (SLN) Finishes Weak at 13.98, Down -8.27

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Silence Therapeutics Plc ADR (NASDAQ: SLN) closed the day trading at $13.98 down -8.27% from the previous closing price of $15.24. In other words, the price has decreased by -$8.27 from its previous closing price. On the day, 0.87 million shares were traded. SLN stock price reached its highest trading level at $15.22 during the session, while it also had its lowest trading level at $13.75.

Ratios:

For a better understanding of SLN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.83 and its Current Ratio is at 9.83. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 03, 2024, initiated with a Buy rating and assigned the stock a target price of $40.

On January 31, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $67.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLN now has a Market Capitalization of 772164288 and an Enterprise Value of 1813290752. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.91 while its Price-to-Book (P/B) ratio in mrq is 4.60. Its current Enterprise Value per Revenue stands at 101.295 whereas that against EBITDA is -37.653.

Stock Price History:

Over the past 52 weeks, SLN has reached a high of $27.72, while it has fallen to a 52-week low of $8.94. The 50-Day Moving Average of the stock is -22.74%, while the 200-Day Moving Average is calculated to be -31.11%.

Shares Statistics:

Over the past 3-months, SLN traded about 175.72K shares per day on average, while over the past 10 days, SLN traded about 132690 shares per day. A total of 46.80M shares are outstanding, with a floating share count of 39.80M. Insiders hold about 14.96% of the company’s shares, while institutions hold 41.90% stake in the company. Shares short for SLN as of 1730332800 were 353316 with a Short Ratio of 2.01, compared to 1727654400 on 312235. Therefore, it implies a Short% of Shares Outstanding of 353316 and a Short% of Float of 1.1900000000000002.

Most Popular